Security key
56270V205
MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX)
CUSIP: 56270V205
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 14,002,438
- Total 13F shares
- 374,558
- Share change
- +82,306
- Total reported value
- $820,064
- Price per share
- $2.19
- Number of holders
- 11
- Value change
- +$209,344
- Number of buys
- 7
- Number of sells
- 4
Report period
Q3 2025
Institutions
11
Top holders
10
MGRX full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
MANGOCEUTICALS, INC. SEC filings
MANGOCEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 56270V205
Recent filing periods:
Top shareholders of MGRX - MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Jacob D. Cohen |
13D/G
|
— |
15%
|
2,044,356
|
$4,599,801 | +$2,526,052 | 21 Jul 2025 | |
| GREENFIELD INVESTMENTS LTD. |
13D/G
|
— |
14%
|
515,000
|
$916,700 | $0 | 13 Dec 2024 | |
| Dr. Kenny Myers |
3/4/5
|
Director |
0.98%
|
136,667
|
$232,333 | — | 09 Sep 2025 | |
| Lorraine Pamela D'Alessio |
3/4/5
|
Director |
0.98%
|
136,667
|
$232,333 | — | 09 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
182,613
|
$277,572 | — | 30 Jun 2025 | |
| Ackerman Capital Advisors, LLC |
13F
|
Company |
0.25%
|
34,500
|
$52,440 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.22%
|
31,000
|
$47,120 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
26,498
|
$40,276 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
10,570
|
$16,066 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.02%
|
2,885
|
$4,385 | — | 30 Jun 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0.01%
|
2,094
|
$3,183 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,850
|
$2,812 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
163
|
$247 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
79
|
$120 | — | 30 Jun 2025 | |
| Jonathan Arango |
3/4/5
|
President, COO and Secretary, Director |
—
class O/S missing
|
1,000,000
|
$1,000,000 | — | 20 Mar 2023 | |
| Amanda Elizabeth Hammer |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
175,000
|
$75,000 | — | 03 Jun 2024 | |
| Antonios Isaac |
3/4/5
|
President, Director |
—
class O/S missing
|
60,000
|
— | — | 10 Apr 2025 |
Institutional Holders of MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) as of Q3 2025
As of 30 Sep 2025,
MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
374,558 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Ackerman Capital Advisors, LLC, XTX Topco Ltd, NORTHERN TRUST CORP, Sunbelt Securities, Inc., OSAIC HOLDINGS, INC., Steward Partners Investment Advisory, LLC, ROYAL BANK OF CANADA, and BANK OF AMERICA CORP /DE/.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
10
Q3 2025 holders
11
Holder diff
1
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.